



Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are both very costly and impact a significant portion of the U.S. population.

A robust approach to modeling costs is necessary for a health technology assessment to accurately describe a medical intervention
Read our latest analysis of healthcare costs in the U.S., including prescription drug and employer contribution trends.
Loading poster...
The importance of understanding the full cost of healthcare—and how and where costs are increasing.

This paper examines implementation of value-based healthcare and how it can link to quality outcomes.